FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DDX10-ARNTL

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DDX10-ARNTL
FusionPDB ID: 21875
FusionGDB2.0 ID: 21875
HgeneTgene
Gene symbol

DDX10

ARNTL

Gene ID

1662

406

Gene nameDEAD-box helicase 10aryl hydrocarbon receptor nuclear translocator like
SynonymsDbp4|HRH-J8BMAL1|BMAL1c|JAP3|MOP3|PASD3|TIC|bHLHe5
Cytomap

11q22.3

11p15.3

Type of geneprotein-codingprotein-coding
Descriptionprobable ATP-dependent RNA helicase DDX10DDX10-NUP98 fusion protein type 2DEAD (Asp-Glu-Ala-Asp) box polypeptide 10DEAD box protein 10DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 10 (RNA helicase)aryl hydrocarbon receptor nuclear translocator-like protein 1ARNT-like protein 1, brain and musclePAS domain containing 3PAS domain-containing protein 3bHLH-PAS protein JAP3basic helix-loop-helix family member e5basic-helix-loop-helix-PAS orphan MOP
Modification date2020031320200322
UniProtAcc

Q13206

Main function of 5'-partner protein: FUNCTION: Putative ATP-dependent RNA helicase.

Q8WYA1

Main function of 5'-partner protein: FUNCTION: Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. The CLOCK-ARNTL2/BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. {ECO:0000269|PubMed:11018023, ECO:0000269|PubMed:12738229, ECO:0000269|PubMed:14672706}.
Ensembl transtripts involved in fusion geneENST idsENST00000322536, ENST00000526794, 
ENST00000534221, 
ENST00000497429, 
ENST00000361003, ENST00000389707, 
ENST00000389708, ENST00000396441, 
ENST00000401424, ENST00000403290, 
ENST00000403482, ENST00000403510, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score14 X 14 X 6=11766 X 7 X 5=210
# samples 178
** MAII scorelog2(17/1176*10)=-2.79028140869866
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(8/210*10)=-1.39231742277876
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: DDX10 [Title/Abstract] AND ARNTL [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DDX10 [Title/Abstract] AND ARNTL [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DDX10(108594189)-ARNTL(13387047), # samples:1
Anticipated loss of major functional domain due to fusion event.DDX10-ARNTL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DDX10-ARNTL seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
DDX10-ARNTL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
DDX10-ARNTL seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneARNTL

GO:0032922

circadian regulation of gene expression

24005054

TgeneARNTL

GO:0045893

positive regulation of transcription, DNA-templated

11441146|12738229|23785138

TgeneARNTL

GO:0045944

positive regulation of transcription by RNA polymerase II

20093779

TgeneARNTL

GO:0051775

response to redox state

11441146



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:108594189/chr11:13387047)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DDX10 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ARNTL (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000322536DDX10chr11108594189-ENST00000396441ARNTLchr1113387047+401820944835121154
ENST00000322536DDX10chr11108594189-ENST00000389707ARNTLchr1113387047+402320944835121154
ENST00000322536DDX10chr11108594189-ENST00000401424ARNTLchr1113387047+402620944835151155
ENST00000322536DDX10chr11108594189-ENST00000389708ARNTLchr1113387047+411620944832151055
ENST00000322536DDX10chr11108594189-ENST00000361003ARNTLchr1113387047+366720944831611037
ENST00000322536DDX10chr11108594189-ENST00000403290ARNTLchr1113387047+402620944835151155
ENST00000322536DDX10chr11108594189-ENST00000403510ARNTLchr1113387047+402020944835121154
ENST00000322536DDX10chr11108594189-ENST00000403482ARNTLchr1113387047+402620944835151155
ENST00000526794DDX10chr11108594189-ENST00000396441ARNTLchr1113387047+39211997234151137
ENST00000526794DDX10chr11108594189-ENST00000389707ARNTLchr1113387047+39261997234151137
ENST00000526794DDX10chr11108594189-ENST00000401424ARNTLchr1113387047+39291997234181138
ENST00000526794DDX10chr11108594189-ENST00000389708ARNTLchr1113387047+40191997231181038
ENST00000526794DDX10chr11108594189-ENST00000361003ARNTLchr1113387047+35701997230641020
ENST00000526794DDX10chr11108594189-ENST00000403290ARNTLchr1113387047+39291997234181138
ENST00000526794DDX10chr11108594189-ENST00000403510ARNTLchr1113387047+39231997234151137
ENST00000526794DDX10chr11108594189-ENST00000403482ARNTLchr1113387047+39291997234181138

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000322536ENST00000396441DDX10chr11108594189-ARNTLchr1113387047+0.0003651250.99963486
ENST00000322536ENST00000389707DDX10chr11108594189-ARNTLchr1113387047+0.0003600540.99964
ENST00000322536ENST00000401424DDX10chr11108594189-ARNTLchr1113387047+0.000461210.9995388
ENST00000322536ENST00000389708DDX10chr11108594189-ARNTLchr1113387047+0.0003021920.9996978
ENST00000322536ENST00000361003DDX10chr11108594189-ARNTLchr1113387047+0.0002801360.9997198
ENST00000322536ENST00000403290DDX10chr11108594189-ARNTLchr1113387047+0.000461210.9995388
ENST00000322536ENST00000403510DDX10chr11108594189-ARNTLchr1113387047+0.0003681010.9996319
ENST00000322536ENST00000403482DDX10chr11108594189-ARNTLchr1113387047+0.000461210.9995388
ENST00000526794ENST00000396441DDX10chr11108594189-ARNTLchr1113387047+0.0003887570.9996113
ENST00000526794ENST00000389707DDX10chr11108594189-ARNTLchr1113387047+0.0003834910.9996165
ENST00000526794ENST00000401424DDX10chr11108594189-ARNTLchr1113387047+0.0004964120.9995036
ENST00000526794ENST00000389708DDX10chr11108594189-ARNTLchr1113387047+0.0003207440.9996793
ENST00000526794ENST00000361003DDX10chr11108594189-ARNTLchr1113387047+0.0003028140.9996972
ENST00000526794ENST00000403290DDX10chr11108594189-ARNTLchr1113387047+0.0004964120.9995036
ENST00000526794ENST00000403510DDX10chr11108594189-ARNTLchr1113387047+0.0003917760.9996082
ENST00000526794ENST00000403482DDX10chr11108594189-ARNTLchr1113387047+0.0004964120.9995036

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DDX10-ARNTL

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DDX10chr11108594189ARNTLchr11133870471997665VFGLDLKDEKTLQAADGFLFVVGCDR
DDX10chr11108594189ARNTLchr11133870472094682VFGLDLKDEKTLQAADGFLFVVGCDR

Top

Potential FusionNeoAntigen Information of DDX10-ARNTL in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DDX10-ARNTL_108594189_13387047.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:01DEKTLQAA0.99620.8715715
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:01LQAADGFLF0.99760.91681120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B58:01KTLQAADGF0.98140.8102918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B58:02KTLQAADGF0.98030.8137918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:17KTLQAADGF0.96970.8546918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:16KTLQAADGF0.96930.7915918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:03KTLQAADGF0.9660.9693918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:25LQAADGFLF0.95950.94211120
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:21QAADGFLFV0.93660.641221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B51:02QAADGFLFV0.93610.69671221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B39:06LKDEKTLQA0.93410.7998514
DDX10-ARNTLchr11108594189chr11133870472094HLA-B51:01QAADGFLFV0.7540.68561221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:03LQAADGFLF0.720.82911120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B47:01LQAADGFLF0.71050.64261120
DDX10-ARNTLchr11108594189chr11133870472094HLA-A32:13KTLQAADGF0.69980.7825918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B13:01LQAADGFLF0.63460.97521120
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:21LQAADGFLFV0.970.63181121
DDX10-ARNTLchr11108594189chr11133870472094HLA-B08:09DLKDEKTLQA0.8610.7111414
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:01KTLQAADGFLF0.99980.9581920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B58:02KTLQAADGFLF0.99970.8812920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B58:01KTLQAADGFLF0.99950.8627920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:03KTLQAADGFLF0.99950.9871920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:16KTLQAADGFLF0.99910.81920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:17KTLQAADGFLF0.9990.8893920
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:22TLQAADGFLFV0.99650.62871021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A32:13KTLQAADGFLF0.99270.9176920
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:27TLQAADGFLFV0.98980.61291021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:13TLQAADGFLFV0.98390.67041021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:30TLQAADGFLFV0.9790.55021021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:24TLQAADGFLFV0.9790.55021021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:67TLQAADGFLFV0.9790.55021021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:60TLQAADGFLFV0.97880.57131021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:11TLQAADGFLFV0.97540.57751021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:38TLQAADGFLFV0.95490.65591021
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:01DEKTLQAADGF0.95270.7486718
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:19TLQAADGFLFV0.94780.57991021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:35TLQAADGFLFV0.94720.56511021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:29TLQAADGFLFV0.91570.55521021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:20TLQAADGFLFV0.90150.55621021
DDX10-ARNTLchr11108594189chr11133870472094HLA-B13:01KTLQAADGFLF0.85080.9821920
DDX10-ARNTLchr11108594189chr11133870472094HLA-C15:06QAADGFLFV0.99830.95951221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C03:07QAADGFLFV0.99820.99241221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C15:04QAADGFLFV0.99590.9631221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C04:06QAADGFLFV0.99550.88871221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C12:04QAADGFLFV0.98250.99591221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C06:03QAADGFLFV0.98010.99621221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C03:19QAADGFLFV0.97030.99221221
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:05QAADGFLFV0.95540.56091221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C12:12QAADGFLFV0.93980.95981221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C08:04QAADGFLFV0.92720.98161221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C08:13QAADGFLFV0.92720.98161221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:05LQAADGFLF0.85510.92981120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:31LQAADGFLF0.82360.93631120
DDX10-ARNTLchr11108594189chr11133870472094HLA-C02:06QAADGFLFV0.77830.97261221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C08:03QAADGFLFV0.66030.98531221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B51:08QAADGFLFV0.47020.53161221
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:05LQAADGFLFV0.9930.61411121
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:02TLQAADGFLFV0.99670.5231021
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:01TLQAADGFLFV0.9790.55021021
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:06DEKTLQAA0.99630.8917715
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:05DEKTLQAA0.99620.8715715
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:03DEKTLQAA0.99460.8631715
DDX10-ARNTLchr11108594189chr11133870472094HLA-C15:02QAADGFLFV0.99890.96131221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C15:05QAADGFLFV0.99870.96591221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:34LQAADGFLF0.99760.91681120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:33LQAADGFLF0.99760.91681120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:27LQAADGFLF0.99760.93861120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:125LQAADGFLF0.99760.91681120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:135LQAADGFLF0.99740.9421120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:24LQAADGFLF0.99650.95741120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:50LQAADGFLF0.9960.93361120
DDX10-ARNTLchr11108594189chr11133870472094HLA-C15:09QAADGFLFV0.99590.9631221
DDX10-ARNTLchr11108594189chr11133870472094HLA-A68:02QAADGFLFV0.99040.72141221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C03:06QAADGFLFV0.98520.99141221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:12LQAADGFLF0.98040.92371120
DDX10-ARNTLchr11108594189chr11133870472094HLA-A69:01QAADGFLFV0.97760.68921221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:53LQAADGFLF0.97490.89051120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:04KTLQAADGF0.97270.637918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B58:06KTLQAADGF0.97120.7438918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:39LQAADGFLF0.96020.8841120
DDX10-ARNTLchr11108594189chr11133870472094HLA-A32:01KTLQAADGF0.95480.7561918
DDX10-ARNTLchr11108594189chr11133870472094HLA-C12:03QAADGFLFV0.94340.98861221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C16:02QAADGFLFV0.94290.9931221
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:06QAADGFLFV0.93660.641221
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:14QAADGFLFV0.93640.58991221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:73LQAADGFLF0.8860.80711120
DDX10-ARNTLchr11108594189chr11133870472094HLA-C16:04QAADGFLFV0.87770.99021221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:54LQAADGFLF0.86460.86141120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:20LQAADGFLF0.85020.95061120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:13LQAADGFLF0.83510.86121120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:02KTLQAADGF0.82980.8489918
DDX10-ARNTLchr11108594189chr11133870472094HLA-B35:28LQAADGFLF0.81470.95231120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B15:30LQAADGFLF0.8050.89961120
DDX10-ARNTLchr11108594189chr11133870472094HLA-C17:01QAADGFLFV0.78250.96991221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B35:20LQAADGFLF0.77630.95731120
DDX10-ARNTLchr11108594189chr11133870472094HLA-B51:09QAADGFLFV0.77520.65431221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B51:14QAADGFLFV0.76870.67111221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C16:01QAADGFLFV0.73950.9831221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C08:01QAADGFLFV0.66030.98531221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C02:02QAADGFLFV0.66020.98381221
DDX10-ARNTLchr11108594189chr11133870472094HLA-C02:10QAADGFLFV0.66020.98381221
DDX10-ARNTLchr11108594189chr11133870472094HLA-B48:02LQAADGFLF0.63490.94071120
DDX10-ARNTLchr11108594189chr11133870472094HLA-C12:02QAADGFLFV0.56060.97781221
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:14LQAADGFLFV0.97070.5991121
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:06LQAADGFLFV0.970.63181121
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:10KTLQAADGFLF0.99980.9581920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:04KTLQAADGFLF0.99970.7337920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B58:06KTLQAADGFLF0.99960.8301920
DDX10-ARNTLchr11108594189chr11133870472094HLA-B57:02KTLQAADGFLF0.99940.9112920
DDX10-ARNTLchr11108594189chr11133870472094HLA-A32:01KTLQAADGFLF0.99760.8965920
DDX10-ARNTLchr11108594189chr11133870472094HLA-A02:03TLQAADGFLFV0.99710.71081021
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:03DEKTLQAADGF0.96320.7385718
DDX10-ARNTLchr11108594189chr11133870472094HLA-B18:05DEKTLQAADGF0.95270.7486718

Top

Potential FusionNeoAntigen Information of DDX10-ARNTL in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DDX10-ARNTL_108594189_13387047.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0401GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0401FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0413GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0413FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0413VFGLDLKDEKTLQAA015
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0413LDLKDEKTLQAADGF318
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0415GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0419GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0422GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0422FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0433GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0433FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0434GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0435GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0435FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0436GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0437GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0437FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0438GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0438FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0440GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0440FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0442GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0444GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0444FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0451GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0455GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0455FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0456GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0456FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0461GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0463GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0463FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0464GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0468GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0468FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0470GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0470FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0472GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0473GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0475GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0476GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0476FGLDLKDEKTLQAAD116
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0479GLDLKDEKTLQAADG217
DDX10-ARNTLchr11108594189chr11133870472094DRB1-0479FGLDLKDEKTLQAAD116

Top

Fusion breakpoint peptide structures of DDX10-ARNTL

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4141KDEKTLQAADGFLFDDX10ARNTLchr11108594189chr11133870472094

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DDX10-ARNTL

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4141KDEKTLQAADGFLF-7.15543-7.26883
HLA-B14:023BVN4141KDEKTLQAADGFLF-4.77435-5.80965
HLA-B52:013W394141KDEKTLQAADGFLF-6.80875-6.92215
HLA-B52:013W394141KDEKTLQAADGFLF-4.20386-5.23916
HLA-A11:014UQ24141KDEKTLQAADGFLF-7.5194-8.5547
HLA-A11:014UQ24141KDEKTLQAADGFLF-6.9601-7.0735
HLA-A24:025HGA4141KDEKTLQAADGFLF-7.52403-7.63743
HLA-A24:025HGA4141KDEKTLQAADGFLF-5.82433-6.85963
HLA-B27:056PYJ4141KDEKTLQAADGFLF-3.28285-4.31815
HLA-B44:053DX84141KDEKTLQAADGFLF-5.91172-6.94702
HLA-B44:053DX84141KDEKTLQAADGFLF-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of DDX10-ARNTL

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DDX10-ARNTLchr11108594189chr11133870471021TLQAADGFLFVACATTACAGGCAGCAGATGGATTTTTGTTTGTC
DDX10-ARNTLchr11108594189chr11133870471120LQAADGFLFTTACAGGCAGCAGATGGATTTTTGTTT
DDX10-ARNTLchr11108594189chr11133870471121LQAADGFLFVTTACAGGCAGCAGATGGATTTTTGTTTGTC
DDX10-ARNTLchr11108594189chr11133870471221QAADGFLFVCAGGCAGCAGATGGATTTTTGTTTGTC
DDX10-ARNTLchr11108594189chr1113387047414DLKDEKTLQAGACCTTAAAGACGAGAAAACATTACAGGCA
DDX10-ARNTLchr11108594189chr1113387047514LKDEKTLQACTTAAAGACGAGAAAACATTACAGGCA
DDX10-ARNTLchr11108594189chr1113387047715DEKTLQAAGACGAGAAAACATTACAGGCAGCA
DDX10-ARNTLchr11108594189chr1113387047718DEKTLQAADGFGACGAGAAAACATTACAGGCAGCAGATGGATTT
DDX10-ARNTLchr11108594189chr1113387047918KTLQAADGFAAAACATTACAGGCAGCAGATGGATTT
DDX10-ARNTLchr11108594189chr1113387047920KTLQAADGFLFAAAACATTACAGGCAGCAGATGGATTTTTGTTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
DDX10-ARNTLchr11108594189chr1113387047015VFGLDLKDEKTLQAAGTGTTTGGATTGGACCTTAAAGACGAGAAAACATTACAGGCAGCA
DDX10-ARNTLchr11108594189chr1113387047116FGLDLKDEKTLQAADTTTGGATTGGACCTTAAAGACGAGAAAACATTACAGGCAGCAGAT
DDX10-ARNTLchr11108594189chr1113387047217GLDLKDEKTLQAADGGGATTGGACCTTAAAGACGAGAAAACATTACAGGCAGCAGATGGA
DDX10-ARNTLchr11108594189chr1113387047318LDLKDEKTLQAADGFTTGGACCTTAAAGACGAGAAAACATTACAGGCAGCAGATGGATTT

Top

Information of the samples that have these potential fusion neoantigens of DDX10-ARNTL

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
PRADDDX10-ARNTLchr11108594189ENST00000322536chr1113387047ENST00000361003TCGA-EJ-7321-01A

Top

Potential target of CAR-T therapy development for DDX10-ARNTL

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to DDX10-ARNTL

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DDX10-ARNTL

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource